Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R42])

The summary for the Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R42]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R42]): - The purpose of this funding opportunity announcement (FOA) is to solicit applications for support of research and development of commercializable biomarker technologies relevant to mental disorders - This FOA will utilize the Small Business Technology Transfer Research (STTR [R41/R42]) mechanisms.

Federal Grant Title:	Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R42])
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-06-015
Type of Funding:	Grant
CFDA Numbers:	93.242
CFDA Descriptions:	Mental Health Research Grants
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Oct 19, 2005
Creation Date:	Oct 19, 2005
Archive Date:	Oct 02, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility: Only United States small business concerns (SBCs) are eligible to submit STTR applications. A small business concern is one that, at the time of award, for both Phase I and Phase II awards, meets all of the following criteria: Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. Is at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's (SBA) Government Contracting Area Office or Office of Size Standards.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed); • NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Cl...; • Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices fo...; • Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Re...; • Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the...; • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...; • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44]); • Pharmacologic Agents and Drugs for Mental Disorders (STTR [R41/R42])
More Grants from the National Institutes of Health: • Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clini...; • Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborativ...; • Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical ...; • Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collab...; • Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science ...